{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for icosapent root_notes_note in Note (approximate match)
Status:
Possibly Marketed Outside US
Source:
21 CFR 333A
(2020)
Source URL:
First approved in 2011
Source:
21 CFR 352
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Zithranol by Elorac Inc.
(2012)
Source URL:
First approved in 2008
Source:
21 CFR 333
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2023)
Source URL:
First approved in 1961
Source:
NDA204820
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NCT01082770: Phase 4 Interventional Unknown status Hemodialysis Catheter Blood Stream Infection
(2010)
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
USAN:IMDUSIRAN SODIUM [USAN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:pegulicianine [INN]
Source URL:
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
Other
Class:
POLYMER
